Introduksjon
Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Gregory T Lucier. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.
Gjennomsnittlig handelslønnsomhet
Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,
Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.
Oppdateringsfrekvens: Daglig
Selskaper med rapporterte insiderposisjoner
SEC-arkiveringene indikerer at Gregory T Lucier har rapporterte beholdninger av handler i følgende selskaper:
Verdipapir | Navn | Siste rapporterte høydepunkter |
---|---|---|
US:XRAY / DENTSPLY SIRONA Inc. | Director | 24 047 |
US:MRVI / Maravai LifeSciences Holdings, Inc. | Director | 109 784 |
US:CTLT / Catalent, Inc. | Director | 0 |
Director | 0 | |
Director | 21 174 | |
US:NUVA / Nuvasive Inc | Director | 0 |
US:IVTY / Invuity, Inc. | Director | 0 |
US:CFN / CareFusion Corporation | Director | 0 |
US:US53217VAC37 / Life Technologies Corp | Chief Executive Officer, Director | 0 |
Hvordan tolke diagrammene
De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Gregory T Lucier. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.
Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.
Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.
Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.
Internkjøp MRVI / Maravai LifeSciences Holdings, Inc. - Analyse av kortsiktig fortjeneste
I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i MRVI / Maravai LifeSciences Holdings, Inc.. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til maks |
Pris ved maks |
Maks fortjeneste ($) |
Maks fortjeneste (%) |
---|---|---|---|---|---|---|---|---|---|---|---|
2020-11-24 | MRVI | LUCIER GREGORY T | 15 000 | 27,0000 | 15 000 | 27,0000 | 405 000 | 269 | 60.6200 | 504 300 | 124,52 |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Internhandel MRVI / Maravai LifeSciences Holdings, Inc. - Analyse av kortsiktig tap
I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i MRVI / Maravai LifeSciences Holdings, Inc.. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til min |
Pris ved min |
Maks tap unngått ($) |
Maks tap unngått (%) |
---|---|---|---|---|---|---|---|
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Innsidernes handelshistorikk
Tabellen viser den komplette listen over innsidehandler gjort av Gregory T Lucier som avslørt til Securies Exchange Comission (SEC).
Fildato | Transaksjonsdato | Skjema | Ticker | Verdipapir | Kode | Aksjer | Gjenværende aksjer | Prosent endring |
Aksje pris |
Transaksjons verdi |
Gjenværende verdi |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-08-12 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
G - Gift | 24 047 | 24 047 | |||||
2025-08-12 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
G - Gift | −24 047 | 82 301 | −22,61 | ||||
2025-08-12 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
A - Award | 3 858 | 106 348 | 3,76 | ||||
2025-07-15 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
A - Award | 203 | 102 490 | 0,20 | ||||
2025-07-11 |
|
4 | MRVI |
MARAVAI LIFESCIENCES HOLDINGS, INC.
Class A Common Stock |
G - Gift | 89 139 | 109 784 | 431,77 | ||||
2025-07-11 |
|
4 | MRVI |
MARAVAI LIFESCIENCES HOLDINGS, INC.
Class A Common Stock |
G - Gift | −89 139 | 55 123 | −61,79 | ||||
2025-06-18 |
|
4 | MRVI |
MARAVAI LIFESCIENCES HOLDINGS, INC.
Class A Common Stock |
A - Award | 89 139 | 144 262 | 161,71 | 2,16 | 192 540 | 311 606 | |
2025-05-27 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
A - Award | 20 189 | 102 288 | 24,59 | ||||
2025-04-15 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
A - Award | 127 | 82 099 | 0,16 | ||||
2025-03-03 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
P - Purchase | 15 142 | 81 971 | 22,66 | 16,51 | 249 994 | 1 353 348 | |
2025-01-29 |
|
4/A | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
P - Purchase | 5 000 | 66 730 | 8,10 | 18,37 | 91 850 | 1 225 823 | |
2025-01-29 |
|
4/A | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
P - Purchase | 1 000 | 21 000 | 5,00 | 18,28 | 18 279 | 383 865 | |
2025-01-14 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
A - Award | 99 | 71 829 | 0,14 | ||||
2024-12-18 |
|
4 | CTLT |
Catalent, Inc.
Common Stock |
D - Sale to Issuer | −36 914 | 0 | −100,00 | ||||
2024-12-09 |
|
4 | MRVI |
MARAVAI LIFESCIENCES HOLDINGS, INC.
Class A Common Stock |
G - Gift | 20 645 | 20 645 | |||||
2024-12-09 |
|
4 | MRVI |
MARAVAI LIFESCIENCES HOLDINGS, INC.
Class A Common Stock |
G - Gift | −20 645 | 55 123 | −27,25 | ||||
2024-11-18 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
P - Purchase | 5 000 | 71 730 | 7,49 | 18,37 | 91 850 | 1 317 673 | |
2024-11-18 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
P - Purchase | 1 000 | 16 000 | 6,67 | 18,28 | 18 279 | 292 469 | |
2024-11-01 |
|
4 | CTLT |
Catalent, Inc.
Common Stock |
A - Award | 4 663 | 36 914 | 14,46 | ||||
2024-10-15 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
A - Award | 69 | 66 730 | 0,10 | ||||
2024-08-09 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
P - Purchase | 8 212 | 66 661 | 14,05 | 24,35 | 199 983 | 1 623 356 | |
2024-07-15 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
A - Award | 75 | 58 449 | 0,13 | ||||
2024-06-03 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
P - Purchase | 3 577 | 58 374 | 6,53 | 27,95 | 99 976 | 1 631 544 | |
2024-05-24 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
A - Award | 11 628 | 54 797 | 26,94 | ||||
2024-05-24 |
|
4 | MRVI |
MARAVAI LIFESCIENCES HOLDINGS, INC.
Class A Common Stock |
A - Award | 20 645 | 75 768 | 37,45 | 10,78 | 222 553 | 816 779 | |
2024-04-15 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
A - Award | 26 | 43 169 | 0,06 | ||||
2024-01-16 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
A - Award | 21 | 43 143 | 0,05 | ||||
2023-11-27 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
P - Purchase | 10 000 | 43 121 | 30,19 | 31,44 | 314 400 | 1 355 730 | |
2023-10-31 |
|
4 | CTLT |
Catalent, Inc.
Common Stock |
A - Award | 6 993 | 32 251 | 27,69 | ||||
2023-10-16 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
A - Award | 49 | 33 121 | 0,15 | ||||
2023-10-03 |
|
4 | CELL |
Bruker Cellular Analysis, Inc.
Common Stock |
D - Sale to Issuer | −136 062 | 0 | −100,00 | ||||
2023-10-03 |
|
4 | CELL |
Bruker Cellular Analysis, Inc.
Common Stock |
M - Exercise | −70 000 | 136 062 | −33,97 | ||||
2023-07-19 |
|
4 | MRVI |
MARAVAI LIFESCIENCES HOLDINGS, INC.
Class A Common Stock |
A - Award | 24 000 | 55 123 | 77,11 | ||||
2023-07-17 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
A - Award | 41 | 33 072 | 0,13 | ||||
2023-06-01 |
|
4 | CELL |
PhenomeX Inc.
Common Stock |
A - Award | 70 000 | 206 062 | 51,45 | ||||
2023-05-26 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
A - Award | 5 419 | 33 031 | 19,63 | ||||
2023-04-18 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
A - Award | 23 | 27 612 | 0,08 | ||||
2023-01-13 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
A - Award | 25 | 27 589 | 0,09 | ||||
2022-11-16 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
A - Award | 6 382 | 27 564 | 30,13 | ||||
2022-11-15 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
P - Purchase | 6 000 | 15 000 | 66,67 | 31,45 | 188 700 | 471 750 | |
2022-10-31 |
|
4 | CTLT |
Catalent, Inc.
Common Stock |
A - Award | 4 149 | 25 258 | 19,66 | ||||
2022-08-01 |
|
4 | BLI |
Berkeley Lights, Inc.
Common Stock |
A - Award | 19 565 | 136 062 | 16,79 | ||||
2022-04-11 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
A - Award | 8 | 21 182 | 0,04 | ||||
2022-03-22 |
|
4 | BLI |
Berkeley Lights, Inc.
Common Stock |
A - Award | 16 666 | 340 989 | 5,14 | ||||
2022-03-15 |
|
4 | BLI |
Berkeley Lights, Inc.
Common Stock |
P - Purchase | 50 000 | 324 323 | 18,23 | 5,24 | 262 240 | 1 701 009 | |
2022-03-01 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
A - Award | 6 | 21 174 | 0,03 | ||||
2022-01-19 |
|
4 | XRAY |
RAM HART SYSTEMS INC
Common Stock |
A - Award | 6 | 21 174 | 0,03 | ||||
2021-11-24 |
|
4 | CTLT |
Catalent, Inc.
Common Stock |
S - Sale | −2 400 | 0 | −100,00 | 127,76 | −306 624 | ||
2021-11-24 |
|
4 | CTLT |
Catalent, Inc.
Common Stock |
S - Sale | −2 668 | 2 400 | −52,64 | 126,98 | −338 783 | 304 752 | |
2021-11-23 |
|
4 | MRVI |
MARAVAI LIFESCIENCES HOLDINGS, INC.
Class A Common Stock |
A - Award | 4 271 | 31 123 | 15,91 | ||||
2021-11-09 |
|
4 | BLI |
Berkeley Lights, Inc.
Common Stock |
P - Purchase | 20 704 | 274 323 | 8,16 | 24,15 | 500 008 | 6 624 983 | |
2021-11-01 |
|
4 | CTLT |
Catalent, Inc.
Common Stock |
A - Award | 1 402 | 21 109 | 7,11 | ||||
2021-10-12 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
A - Award | 6 | 21 169 | 0,03 | 60,01 | 331 | 1 270 324 | |
2021-07-13 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
A - Award | 5 | 21 163 | 0,02 | 64,18 | 331 | 1 358 243 | |
2021-06-07 |
|
4 | BLI |
Berkeley Lights, Inc.
Common Stock |
P - Purchase | 5 000 | 253 619 | 2,01 | 41,12 | 205 590 | 10 428 306 | |
2021-06-01 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
A - Award | 3 008 | 21 158 | 16,57 | ||||
2021-05-20 |
|
4 | NUVA |
NUVASIVE INC
RSUs |
M - Exercise | −3 095 | 0 | −100,00 | ||||
2021-05-20 |
|
4 | NUVA |
NUVASIVE INC
RSUs |
M - Exercise | −2 577 | 0 | −100,00 | ||||
2021-05-20 |
|
4 | NUVA |
NUVASIVE INC
RSUs |
M - Exercise | −3 725 | 0 | −100,00 | ||||
2021-05-20 |
|
4 | NUVA |
NUVASIVE INC
RSUs |
M - Exercise | −1 416 | 0 | −100,00 | ||||
2021-05-20 |
|
4 | NUVA |
NUVASIVE INC
RSUs |
M - Exercise | −8 312 | 0 | −100,00 | ||||
2021-05-20 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
F - Taxes | −8 405 | 257 939 | −3,16 | 70,34 | −591 208 | 18 143 429 | |
2021-05-20 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
M - Exercise | 19 125 | 266 344 | 7,74 | ||||
2021-05-18 |
|
4 | BLI |
Berkeley Lights, Inc.
Stock Option (Right to Buy) |
A - Award | 4 900 | 4 900 | |||||
2021-05-18 |
|
4 | BLI |
Berkeley Lights, Inc.
Common Stock |
A - Award | 1 400 | 248 619 | 0,57 | ||||
2021-05-04 |
|
4 | NUVA |
NUVASIVE INC
PRSUs |
M - Exercise | −4 046 | 0 | −100,00 | ||||
2021-05-04 |
|
4 | NUVA |
NUVASIVE INC
PRSUs |
M - Exercise | −38 527 | 0 | −100,00 | ||||
2021-05-04 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
F - Taxes | −16 722 | 247 219 | −6,34 | 71,45 | −1 194 787 | 17 663 798 | |
2021-05-04 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
M - Exercise | 42 573 | 263 941 | 19,23 | ||||
2021-04-12 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
A - Award | 8 | 18 150 | 0,04 | ||||
2021-03-05 |
|
4/A | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
P - Purchase | 9 000 | 9 000 | 58,75 | 528 752 | 528 752 | ||
2021-03-04 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
P - Purchase | 5 000 | 23 142 | 27,56 | 58,95 | 294 750 | 1 364 223 | |
2021-02-12 |
|
4 | NUVA |
NUVASIVE INC
PRSUs |
A - Award | 4 045 | 4 045 | |||||
2021-01-12 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
A - Award | 9 | 18 142 | 0,05 | ||||
2020-11-25 |
|
4 | MRVI |
MARAVAI LIFESCIENCES HOLDINGS, INC.
Class A Common Stock |
P - Purchase | 15 000 | 26 852 | 126,56 | 27,00 | 405 000 | 725 004 | |
2020-11-23 |
|
4 | MRVI |
MARAVAI LIFESCIENCES HOLDINGS, INC.
Class A Common Stock |
A - Award | 11 852 | 11 852 | |||||
2020-11-02 |
|
4 | CTLT |
Catalent, Inc.
Common Stock |
A - Award | 2 125 | 19 707 | 12,09 | ||||
2020-10-13 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
A - Award | 11 | 18 099 | 0,06 | ||||
2020-08-28 |
|
4 | CTLT |
Catalent, Inc.
Common Stock |
A - Award | 661 | 17 582 | 3,91 | ||||
2020-08-03 |
|
4 | CTLT |
Catalent, Inc.
Common Stock |
S - Sale | X | −24 000 | 16 921 | −58,65 | 90,09 | −2 162 160 | 1 524 413 |
2020-07-20 |
|
4 | BLI |
Berkeley Lights, Inc.
Stock Option |
A - Award | 125 000 | 125 000 | |||||
2020-07-20 |
|
4 | BLI |
Berkeley Lights, Inc.
Common Stock |
P - Purchase | 22 727 | 22 727 | 22,00 | 499 994 | 499 994 | ||
2020-07-10 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
A - Award | 11 | 18 088 | 0,06 | ||||
2020-05-29 |
|
4 | NUVA |
NUVASIVE INC
RSUs |
A - Award | 3 095 | 3 095 | |||||
2020-05-22 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
A - Award | 4 766 | 18 077 | 35,81 | ||||
2020-04-14 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
A - Award | 38 | 13 311 | 0,29 | ||||
2020-03-03 |
|
4 | NUVA |
NUVASIVE INC
PRSUs |
M - Exercise | −33 695 | 0 | −100,00 | ||||
2020-03-03 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
F - Taxes | −14 547 | 221 368 | −6,17 | 65,81 | −957 338 | 14 568 228 | |
2020-03-03 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
M - Exercise | 33 695 | 235 915 | 16,66 | ||||
2020-02-14 |
|
4 | CTLT |
Catalent, Inc.
Common Stock |
P - Purchase | 2 000 | 40 921 | 5,14 | 59,71 | 119 420 | 2 443 393 | |
2020-01-14 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
A - Award | 6 | 13 273 | 0,04 | ||||
2019-11-20 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
S - Sale | X | −8 638 | 202 220 | −4,10 | 73,46 | −634 547 | 14 855 081 |
2019-11-20 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
S - Sale | X | −20 831 | 210 858 | −8,99 | 72,79 | −1 516 288 | 15 348 354 |
2019-10-16 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
A - Award | 6 | 13 267 | 0,05 | ||||
2019-09-11 |
|
4 | CTLT |
Catalent, Inc.
Common Stock |
P - Purchase | 2 000 | 38 921 | 5,42 | 51,64 | 103 280 | 2 009 880 | |
2019-09-11 |
|
4 | CTLT |
Catalent, Inc.
Common Stock |
G - Gift | 5 068 | 5 068 | |||||
2019-09-11 |
|
4 | CTLT |
Catalent, Inc.
Common Stock |
G - Gift | −5 068 | 36 921 | −12,07 | ||||
2019-08-26 |
|
4 | CTLT |
Catalent, Inc.
Common Stock |
A - Award | 3 167 | 41 989 | 8,16 | ||||
2019-07-16 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
A - Award | 5 | 13 261 | 0,04 | ||||
2019-05-29 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
A - Award | 3 256 | 13 256 | 32,56 | ||||
2019-05-24 |
|
4 | NUVA |
NUVASIVE INC
PRSUs |
M - Exercise | −78 702 | 0 | −100,00 | ||||
2019-05-24 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
F - Taxes | −39 020 | 231 689 | −14,41 | 62,27 | −2 429 775 | 14 427 274 | |
2019-05-24 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
M - Exercise | 78 702 | 270 709 | 40,99 | ||||
2019-05-23 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
P - Purchase | 10 000 | 10 000 | 53,60 | 536 047 | 536 047 | ||
2019-05-13 |
|
4 | CTLT |
Catalent, Inc.
Common Stock |
P - Purchase | 2 000 | 38 822 | 5,43 | 45,08 | 90 160 | 1 750 096 | |
2019-05-10 |
|
4 | NUVA |
NUVASIVE INC
RSUs |
A - Award | 2 577 | 2 577 | |||||
2019-05-10 |
|
4 | NUVA |
NUVASIVE INC
PRSUs |
A - Award | 78 702 | 78 702 | |||||
2019-03-05 |
|
4 | NUVA |
NUVASIVE INC
PRSUs |
M - Exercise | −60 010 | 0 | −100,00 | ||||
2019-03-05 |
|
4 | NUVA |
NUVASIVE INC
PRSUs |
M - Exercise | −19 804 | 0 | −100,00 | ||||
2019-03-05 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
F - Taxes | −38 769 | 192 007 | −16,80 | 58,48 | −2 267 211 | 11 228 569 | |
2019-03-05 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
M - Exercise | 79 814 | 230 776 | 52,87 | ||||
2019-02-07 |
|
4 | NUVA |
NUVASIVE INC
PRSUs |
A - Award | 19 804 | 19 804 | |||||
2019-02-07 |
|
4 | NUVA |
NUVASIVE INC
PRSUs |
A - Award | 38 527 | 38 527 | |||||
2019-02-07 |
|
5 | NUVA |
NUVASIVE INC
PRSUs |
A - Award | 33 695 | 33 695 | |||||
2019-02-04 |
|
4 | NUVA |
NUVASIVE INC
PRSUs |
M - Exercise | −13 997 | 0 | −100,00 | ||||
2019-02-04 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
F - Taxes | −4 995 | 150 962 | −3,20 | 49,13 | −245 404 | 7 416 763 | |
2019-02-04 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
M - Exercise | 13 997 | 155 957 | 9,86 | ||||
2018-10-23 |
|
4 | IVTY |
Invuity, Inc.
Director Stock Option (right to buy) |
D - Sale to Issuer | −28 900 | 0 | −100,00 | ||||
2018-10-23 |
|
4 | IVTY |
Invuity, Inc.
Director Stock Option (right to buy) |
D - Sale to Issuer | −24 648 | 0 | −100,00 | ||||
2018-10-23 |
|
4 | IVTY |
Invuity, Inc.
Common Stock |
D - Sale to Issuer | −18 245 | 0 | −100,00 | ||||
2018-10-23 |
|
4 | IVTY |
Invuity, Inc.
Common Stock |
D - Sale to Issuer | −52 231 | 0 | −100,00 | ||||
2018-10-23 |
|
4 | IVTY |
Invuity, Inc.
Common Stock |
D - Sale to Issuer | −99 219 | 52 231 | −65,51 | ||||
2018-08-24 |
|
4 | CTLT |
Catalent, Inc.
Common Stock |
A - Award | 4 183 | 36 822 | 12,82 | ||||
2018-06-13 |
|
4 | IVTY |
Invuity, Inc.
Common Stock |
A - Award | 34 246 | 151 450 | 29,22 | ||||
2018-03-19 |
|
4 | IVTY |
Invuity, Inc.
Common Stock |
P - Purchase | 64 158 | 117 204 | 120,95 | 3,90 | 249 921 | 456 556 | |
2018-03-08 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
P - Purchase | 6 000 | 141 516 | 4,43 | 50,30 | 301 800 | 7 118 255 | |
2018-03-05 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
P - Purchase | 6 000 | 135 516 | 4,63 | 48,57 | 291 420 | 6 582 012 | |
2018-02-05 |
|
4 | NUVA |
NUVASIVE INC
PRSUs |
M - Exercise | −13 998 | 13 997 | −50,00 | ||||
2018-02-05 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
F - Taxes | −4 907 | 129 516 | −3,65 | 48,50 | −237 990 | 6 281 526 | |
2018-02-05 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
M - Exercise | 13 998 | 134 423 | 11,62 | ||||
2017-08-29 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
P - Purchase | 2 000 | 120 425 | 1,69 | 61,52 | 123 040 | 7 408 546 | |
2017-08-28 |
|
4 | CTLT |
Catalent, Inc.
Common Stock |
A - Award | 3 976 | 32 639 | 13,87 | ||||
2017-08-18 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
P - Purchase | 5 000 | 118 245 | 4,42 | 66,22 | 331 100 | 7 830 184 | |
2017-06-14 |
|
4 | IVTY |
Invuity, Inc.
Common Stock |
A - Award | 17 985 | 53 046 | 51,30 | ||||
2017-02-16 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
S - Sale | X | −17 286 | 112 996 | −13,27 | 72,78 | −1 258 075 | 8 223 849 |
2017-02-13 |
|
5 | NUVA |
NUVASIVE INC
PRSUs |
A - Award | 112 491 | 112 491 | |||||
2017-02-10 |
|
4 | NUVA |
NUVASIVE INC
PRSUs |
A - Award | 60 010 | 60 010 | |||||
2017-02-03 |
|
4 | NUVA |
NUVASIVE INC
PRSUs |
M - Exercise | −13 998 | 27 995 | −33,33 | ||||
2017-02-03 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
F - Taxes | −5 399 | 130 282 | −3,98 | 70,76 | −382 033 | 9 218 754 | |
2017-02-03 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
M - Exercise | 13 998 | 135 681 | 11,50 | ||||
2016-08-26 |
|
4 | CTLT |
Catalent, Inc.
Common Stock |
A - Award | 5 595 | 28 663 | 24,25 | ||||
2016-06-21 |
|
4 | IVTY |
Invuity, Inc.
Restricted Stock Units |
M - Exercise | −12 800 | 0 | −100,00 | ||||
2016-06-21 |
|
4 | IVTY |
Invuity, Inc.
Common Stock |
M - Exercise | 12 800 | 35 061 | 57,50 | ||||
2016-06-13 |
|
4 | IVTY |
Invuity, Inc.
Common Stock |
P - Purchase | 8 442 | 22 261 | 61,09 | 7,56 | 63 861 | 168 398 | |
2016-06-07 |
|
4 | IVTY |
Invuity, Inc.
Common Stock |
P - Purchase | 5 601 | 13 819 | 68,16 | 7,00 | 39 207 | 96 733 | |
2016-06-07 |
|
4 | IVTY |
Invuity, Inc.
Common Stock |
P - Purchase | 26 728 | 26 728 | 6,90 | 184 423 | 184 423 | ||
2016-06-07 |
|
4/A | IVTY |
Invuity, Inc.
Common Stock |
P - Purchase | 8 218 | 8 218 | 6,90 | 56 704 | 56 704 | ||
2016-05-23 |
|
4 | IVTY |
Invuity, Inc.
Restricted Stock Units |
A - Award | 12 800 | 12 800 | |||||
2016-05-23 |
|
4 | IVTY |
Invuity, Inc.
Director Stock Option (right to buy) |
A - Award | 26 400 | 26 400 | |||||
2016-02-03 |
|
4 | NUVA |
NUVASIVE INC
PRSUs |
A - Award | −13 998 | 41 993 | −25,00 | ||||
2016-02-03 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
F - Taxes | −5 311 | 121 178 | −4,20 | 46,60 | −247 493 | 5 646 895 | |
2016-02-03 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
M - Exercise | 13 998 | 126 489 | 12,44 | ||||
2016-01-28 |
|
4 | NUVA |
NUVASIVE INC
PRSUs |
A - Award | 55 991 | 55 991 | |||||
2015-07-31 |
|
4/A | CTLT |
Catalent, Inc.
Common Stock |
A - Award | 4 241 | 23 068 | 22,53 | ||||
2015-07-30 |
|
4 | CTLT |
Catalent, Inc.
Common Stock |
A - Award | 4 241 | 11 070 | 62,10 | ||||
2015-06-22 |
|
4 | IVTY |
Invuity, Inc.
Series F Preferred Stock |
C - Conversion | −17 427 | 0 | −100,00 | ||||
2015-06-22 |
|
4 | IVTY |
Invuity, Inc.
Common Stock |
C - Conversion | 18 245 | 18 245 | |||||
2015-06-17 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
P - Purchase | X | 4 491 | 112 491 | 4,16 | 49,49 | 222 279 | 5 567 675 |
2015-06-15 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
P - Purchase | X | 5 000 | 108 000 | 4,85 | 49,97 | 249 856 | 5 396 890 |
2015-06-15 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
P - Purchase | X | 3 000 | 103 000 | 3,00 | 50,31 | 150 923 | 5 181 693 |
2015-06-11 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
P - Purchase | X | 5 000 | 100 000 | 5,26 | 49,93 | 249 630 | 4 992 600 |
2015-06-11 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
P - Purchase | X | 5 000 | 95 000 | 5,56 | 48,27 | 241 367 | 4 585 973 |
2015-06-09 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
P - Purchase | X | 5 000 | 90 000 | 5,88 | 49,36 | 246 786 | 4 442 139 |
2015-06-09 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
P - Purchase | X | 5 000 | 85 000 | 6,25 | 49,17 | 245 830 | 4 179 118 |
2015-06-05 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
P - Purchase | X | 5 000 | 80 000 | 6,67 | 49,67 | 248 372 | 3 973 952 |
2015-06-05 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
P - Purchase | X | 5 000 | 75 000 | 7,14 | 49,75 | 248 742 | 3 731 122 |
2015-06-03 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
P - Purchase | X | 5 000 | 70 000 | 7,69 | 49,85 | 249 228 | 3 489 199 |
2015-06-03 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
P - Purchase | X | 3 000 | 65 000 | 4,84 | 50,15 | 150 464 | 3 260 056 |
2015-05-28 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
P - Purchase | 34 000 | 62 000 | 121,43 | 49,25 | 1 674 531 | 3 053 556 | |
2015-05-04 | 3 | CTLT |
Catalent, Inc.
Common Stock |
37 654 | ||||||||
2015-05-04 | 3 | CTLT |
Catalent, Inc.
Common Stock |
37 654 | ||||||||
2015-03-19 |
|
4 | CFN |
CAREFUSION Corp
Restricted Stock Units |
D - Sale to Issuer | −2 874 | 0 | −100,00 | ||||
2015-03-19 |
|
4 | CFN |
CAREFUSION Corp
Common Stock |
D - Sale to Issuer | −34 103 | 0 | −100,00 | ||||
2014-11-06 |
|
4 | CFN |
CAREFUSION Corp
Restricted Stock Units |
M - Exercise | −4 275 | 0 | −100,00 | ||||
2014-11-06 |
|
4 | CFN |
CAREFUSION Corp
Common Stock |
M - Exercise | 4 275 | 34 103 | 14,33 | ||||
2014-11-06 |
|
4 | CFN |
CAREFUSION Corp
Restricted Stock Units |
A - Award | 2 874 | 2 874 | |||||
2014-08-08 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
A - Award | 2 000 | 28 000 | 7,69 | 35,50 | 71 000 | 994 000 | |
2014-08-06 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
A - Award | 2 000 | 26 000 | 8,33 | 36,50 | 73 000 | 949 000 | |
2014-05-23 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
A - Award | 3 725 | 37 453 | 11,04 | ||||
2014-05-20 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
A - Award | 2 000 | 24 000 | 9,09 | 33,00 | 66 000 | 792 000 | |
2014-05-20 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
A - Award | 2 000 | 22 000 | 10,00 | 33,70 | 67 400 | 741 400 | |
2014-05-16 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
A - Award | 10 000 | 20 000 | 100,00 | 33,80 | 338 000 | 676 000 | |
2014-05-08 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
A - Award | 6 077 | 10 000 | 154,91 | 34,00 | 206 618 | 340 000 | |
2014-05-08 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
A - Award | 3 923 | 3 923 | 34,00 | 133 382 | 133 382 | ||
2014-02-04 |
|
4 | LIFE |
Life Technologies Corp
Restricted Stock |
D - Sale to Issuer | −3 495 | 0 | −100,00 | ||||
2014-02-04 |
|
4 | LIFE |
Life Technologies Corp
Restricted Stock |
D - Sale to Issuer | −2 106 | 0 | −100,00 | ||||
2014-02-04 |
|
4 | LIFE |
Life Technologies Corp
Restricted Stock |
D - Sale to Issuer | −2 136 | 0 | −100,00 | ||||
2014-02-04 |
|
4 | LIFE |
Life Technologies Corp
Restricted Stock |
D - Sale to Issuer | −6 427 | 0 | −100,00 | ||||
2014-02-04 |
|
4 | LIFE |
Life Technologies Corp
Restricted Stock Units |
D - Sale to Issuer | −75 060 | 0 | −100,00 | ||||
2014-02-04 |
|
4 | LIFE |
Life Technologies Corp
Restricted Stock Units |
D - Sale to Issuer | −69 003 | 0 | −100,00 | ||||
2014-02-04 |
|
4 | LIFE |
Life Technologies Corp
Restricted Stock Units |
D - Sale to Issuer | −52 268 | 0 | −100,00 | ||||
2014-02-04 |
|
4 | LIFE |
Life Technologies Corp
Restricted Stock Units |
D - Sale to Issuer | −17 423 | 52 268 | −25,00 | ||||
2014-02-04 |
|
4 | LIFE |
Life Technologies Corp
Stock Options |
D - Sale to Issuer | −485 829 | 0 | −100,00 | 22,23 | −10 799 979 | ||
2014-02-04 |
|
4 | LIFE |
Life Technologies Corp
Stock Options |
D - Sale to Issuer | −70 000 | 0 | −100,00 | 31,26 | −2 188 200 | ||
2014-02-04 |
|
4 | LIFE |
Life Technologies Corp
Stock Options |
D - Sale to Issuer | −85 000 | 0 | −100,00 | 32,26 | −2 742 100 | ||
2014-02-04 |
|
4 | LIFE |
Life Technologies Corp
Stock Options |
D - Sale to Issuer | −92 768 | 0 | −100,00 | 32,69 | −3 032 586 | ||
2014-02-04 |
|
4 | LIFE |
Life Technologies Corp
Stock Options |
D - Sale to Issuer | −210 000 | 0 | −100,00 | 37,33 | −7 839 300 | ||
2014-02-04 |
|
4 | LIFE |
Life Technologies Corp
Stock Options |
D - Sale to Issuer | −85 000 | 0 | −100,00 | 38,43 | −3 266 550 | ||
2014-02-04 |
|
4 | LIFE |
Life Technologies Corp
Stock Options |
D - Sale to Issuer | −160 028 | 0 | −100,00 | 48,91 | −7 826 969 | ||
2014-02-04 |
|
4 | LIFE |
Life Technologies Corp
Stock Options |
D - Sale to Issuer | −243 407 | 0 | −100,00 | 52,00 | −12 657 164 | ||
2014-02-04 |
|
4 | LIFE |
Life Technologies Corp
Common Stock |
D - Sale to Issuer | −81 072 | 0 | −100,00 | 76,13 | −6 172 098 | ||
2014-02-04 |
|
4 | LIFE |
Life Technologies Corp
Common Stock |
D - Sale to Issuer | −28 945 | 0 | −100,00 | 76,13 | −2 203 618 | ||
2014-02-04 |
|
4 | LIFE |
Life Technologies Corp
Common Stock |
D - Sale to Issuer | −456 046 | 0 | −100,00 | 76,13 | −34 719 329 | ||
2014-01-22 |
|
4 | LIFE |
Life Technologies Corp
Performance Restricted Stock Units |
D - Sale to Issuer | −55 422 | 0 | −100,00 | ||||
2014-01-09 |
|
4 | LIFE |
Life Technologies Corp
Restricted Stock |
A - Award | 6 427 | 6 427 | |||||
2014-01-09 |
|
4 | LIFE |
Life Technologies Corp
Common Stock |
A - Award | 50 124 | 81 072 | 161,96 | 75,85 | 3 801 880 | 6 149 301 | |
2013-12-05 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
A - Award | 1 416 | 1 416 | |||||
2013-12-05 |
|
4 | NUVA |
NUVASIVE INC
Common Stock |
A - Award | 8 312 | 8 312 | |||||
2013-11-06 |
|
4 | CFN |
CAREFUSION Corp
Restricted Stock Units |
A - Award | 4 275 | 4 275 | |||||
2013-11-06 |
|
4 | CFN |
CAREFUSION Corp
Restricted Stock Units |
M - Exercise | −4 515 | 0 | −100,00 | ||||
2013-11-06 |
|
4 | CFN |
CAREFUSION Corp
Common Stock |
M - Exercise | 4 515 | 29 828 | 17,84 | ||||
2013-04-16 |
|
4 | CFN |
CAREFUSION Corp
Restricted Stock Units |
A - Award | 4 515 | 4 515 | |||||
2013-04-03 |
|
4 | LIFE |
Life Technologies Corp
Restricted Stock Units |
M - Exercise | −23 002 | 69 003 | −25,00 | ||||
2013-04-03 |
|
4 | LIFE |
Life Technologies Corp
Common Stock |
F - Taxes | −12 003 | 28 945 | −29,31 | 65,75 | −789 197 | 1 903 134 | |
2013-04-03 |
|
4 | LIFE |
Life Technologies Corp
Common Stock |
M - Exercise | 23 002 | 40 948 | 128,17 | 65,75 | 1 512 382 | 2 692 331 | |
2013-04-03 |
|
4 | LIFE |
Life Technologies Corp
Restricted Stock Units |
M - Exercise | −37 530 | 75 060 | −33,33 | ||||
2013-04-03 |
|
4 | LIFE |
Life Technologies Corp
Common Stock |
F - Taxes | −19 584 | 17 946 | −52,18 | 64,57 | −1 264 539 | 1 158 773 | |
2013-04-03 |
|
4 | LIFE |
Life Technologies Corp
Common Stock |
M - Exercise | 37 530 | 37 530 | 64,57 | 2 423 312 | 2 423 312 | ||
2013-04-02 |
|
4 | LIFE |
Life Technologies Corp
Restricted Stock Units |
A - Award | 69 691 | 69 691 | |||||
2013-04-02 |
|
4 | LIFE |
Life Technologies Corp
Performance Restricted Stock Units |
A - Award | 34 813 | 34 813 | |||||
2013-03-18 |
|
4 | LIFE |
Life Technologies Corp
Restricted Stock |
A - Award | 2 136 | 2 136 | |||||
2013-03-18 |
|
4 | LIFE |
Life Technologies Corp
Common Stock |
A - Award | 8 544 | 30 948 | 38,14 | 63,20 | 540 000 | 1 955 926 | |
2013-03-05 |
|
4 | LIFE |
Life Technologies Corp
Restricted Stock Units |
M - Exercise | −70 588 | 0 | −100,00 | ||||
2013-03-05 |
|
4 | LIFE |
Life Technologies Corp
Common Stock |
F - Taxes | −34 379 | 456 046 | −7,01 | 59,54 | −2 046 926 | 27 152 979 | |
2013-03-05 |
|
4 | LIFE |
Life Technologies Corp
Common Stock |
M - Exercise | 70 588 | 490 425 | 16,81 | 59,54 | 4 202 810 | 29 199 904 | |
2013-02-12 |
|
4 | LIFE |
Life Technologies Corp
Common Stock |
G - Gift | −1 950 | 291 586 | −0,66 | 51,19 | −99 820 | 14 926 282 | |
2012-12-28 |
|
4 | LIFE |
Life Technologies Corp
Stock Options |
M - Exercise | X | −150 655 | 0 | −100,00 | |||
2012-12-28 |
|
4 | LIFE |
Life Technologies Corp
Common Stock |
M - Exercise | X | 150 655 | 444 191 | 51,32 | 19,01 | 2 863 952 | 8 444 069 |
2012-12-28 |
|
4 | LIFE |
Life Technologies Corp
Stock Options |
M - Exercise | X | −356 697 | 150 655 | −70,31 | |||
2012-12-28 |
|
4 | LIFE |
Life Technologies Corp
Common Stock |
D - Sale to Issuer | X | −29 744 | 293 536 | −9,20 | 49,69 | −1 477 979 | 14 585 799 |
2012-12-28 |
|
4 | LIFE |
Life Technologies Corp
Common Stock |
D - Sale to Issuer | X | −326 953 | 323 280 | −50,28 | 48,96 | −16 007 619 | 15 827 784 |
2012-12-28 |
|
4 | LIFE |
Life Technologies Corp
Common Stock |
M - Exercise | X | 356 697 | 650 233 | 121,52 | 19,01 | 6 780 810 | 12 360 927 |
2012-11-26 |
|
4 | LIFE |
Life Technologies Corp
Restricted Stock Units |
M - Exercise | −161 943 | 0 | −100,00 | ||||
2012-11-26 |
|
4 | LIFE |
Life Technologies Corp
Common Stock |
F - Taxes | −75 595 | 293 536 | −20,48 | 49,22 | −3 720 786 | 14 447 837 | |
2012-11-26 |
|
4 | LIFE |
Life Technologies Corp
Common Stock |
M - Exercise | 161 943 | 369 131 | 78,16 | 49,22 | 7 970 834 | 18 168 623 | |
2012-11-06 |
|
4 | CFN |
CAREFUSION Corp
Restricted Stock Units |
M - Exercise | −6 019 | 0 | −100,00 | ||||
2012-11-06 |
|
4 | CFN |
CAREFUSION Corp
Common Stock |
M - Exercise | 6 019 | 25 313 | 31,20 | ||||
2012-09-18 |
|
4 | LIFE |
Life Technologies Corp
Common Stock |
S - Sale | X | −169 868 | 207 188 | −45,05 | 50,00 | −8 493 400 | 10 359 395 |
2012-04-04 |
|
4 | LIFE |
Life Technologies Corp
Restricted Stock |
A - Award | 2 106 | 2 106 | |||||
2012-04-04 |
|
4 | LIFE |
Life Technologies Corp
Common Stock |
A - Award | 8 425 | 356 535 | 2,42 | 46,59 | 392 500 | 16 610 961 | |
2012-04-04 |
|
4 | LIFE |
Life Technologies Corp
Stock Options |
A - Award | 160 028 | 160 028 | |||||
2012-04-04 |
|
4 | LIFE |
Life Technologies Corp
Restricted Stock Units |
A - Award | 92 005 | 92 005 | |||||
2012-04-04 |
|
4 | LIFE |
Life Technologies Corp
Restricted Stock Units |
M - Exercise | −37 531 | 112 590 | −25,00 | ||||
2012-04-04 |
|
4 | LIFE |
Life Technologies Corp
Common Stock |
F - Taxes | −17 520 | 368 121 | −4,54 | 48,91 | −856 903 | 18 004 815 | |
2012-04-04 |
|
4 | LIFE |
Life Technologies Corp
Common Stock |
M - Exercise | 37 531 | 385 641 | 10,78 | 48,91 | 1 835 641 | 18 861 718 |